Acute neurocognitive effects of epigallocatechin gallate (EGCG)

Author(s)

Scholey, Andrew; Downey, Luke A.; Ciorciari, Joseph; Pipingas, Andrew; Nolidin, Karen; Finn, Melissa; Wines, Melissa; Catchlove, Sarah; Terrens, Alirra; Barlow, Emma; Gordon, Leanne; Stough, Con

Available versions

Abstract

Green tea is reported to have wide ranging beneficial health outcomes across epidemiological studies, which have been attributed to its flavonoid content. We investigated whether the flavonoid epigallocatechin gallate (EGCG) modulates brain activity and self-reported mood in a double-blind, placebo controlled crossover study. Participants completed baseline assessments of cognitive and cardiovascular functioning, mood and a resting state electroencephalogram (EEG) before and then 120 min following administration of 300 mg EGCG or matched placebo. EGCG administration was associated with a significant overall increase in alpha, beta and theta activity, also reflected in overall EEG activity, more dominant in midline frontal and central regions, specifically in the frontal gyrus and medial frontal gyrus. In comparison to placebo the EGCG treatment also increased self-rated calmness and reduced self rated stress. This pattern of results suggests that participants in the EGCG condition may have been in a more relaxed and attentive state after consuming EGCG. This is in keeping with the widespread consumption of green tea for its purported relaxing/refreshing properties. The modulation of brain function due to EGCG is deserving of further controlled human studies.

Publication year

2012

Publication type

Journal article

Source

Appetite, Vol. 58, no. 2 (Apr 2012), pp. 767-770

ISSN

0195-6663

Publisher

Elsevier

Copyright

Copyright © 2011 Elsevier Ltd. The accepted manuscript is reproduced in accordance with the copyright policy of the publisher.

Details